J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
Wall Street
Price Targets
JBCHEPHARM Price Targets Summary
J B Chemicals and Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for JBCHEPHARM is 1 775.27 INR with a low forecast of 1 148.88 INR and a high forecast of 2 310 INR.
Revenue
Forecast
Revenue Estimate
J B Chemicals and Pharmaceuticals Ltd
For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's revenue is 14%. The projected CAGR for the next 4 years is 14%.
Operating Income
Forecast
Operating Income Estimate
J B Chemicals and Pharmaceuticals Ltd
For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's operating income is 19%. The projected CAGR for the next 4 years is 22%.
Net Income
Forecast
Net Income Estimate
J B Chemicals and Pharmaceuticals Ltd
For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's net income is 19%. The projected CAGR for the next 4 years is 24%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is JBCHEPHARM's stock price target?
Price Target
1 775.27
INR
According to Wall Street analysts, the average 1-year price target for JBCHEPHARM is 1 775.27 INR with a low forecast of 1 148.88 INR and a high forecast of 2 310 INR.
What is J B Chemicals and Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
14%
For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's revenue is 14%. The projected CAGR for the next 4 years is 14%.
What is J B Chemicals and Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
22%
For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's operating income is 19%. The projected CAGR for the next 4 years is 22%.
What is J B Chemicals and Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
24%
For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's net income is 19%. The projected CAGR for the next 4 years is 24%.